Naturopathic Profession Regulations
Regulation- Registration
- R-018-2022
- Source
- Unofficial consolidation PDF (justice.gov.nt.ca)
- Under
- Health and Social Services Professions Act
This is an unofficial reading copy parsed from the Department of Justice consolidation PDF above — itself an office consolidation, not an official statement of the law. The authoritative text is in the Revised Statutes of the Northwest Territories, 1988 and the annual Statutes volumes.
- s.4 amended by R-107-2024,s.2
- s.9 amended by R-072-2022,s.2
- s.16 amended by Health and Social Services Professions Act
- s.sched_B amended by R-089-2025,s.2 in force Oct. 1, 2025
REGULATIONS
The Commissioner, on the recommendation of the Minister, under section 67 of the Health and Social Services Professions Act and every enabling power, makes the Naturopathic Profession Regulations.
Definitions
In these regulations,
"accredited naturopathic school" means a naturopathic medical program accredited by the Council on Naturopathic Medical Education; (école de naturopathie agréée)
"compound" means to mix with one or more other ingredients; (préparer)
"Council on Naturopathic Medical Education" means the programmatic accrediting agency for naturopathic medical education programs that qualify graduates for naturopathic registration in Canada and the United States, recognized by the Canadian Association of Naturopathic Doctors, the American Association of Naturopathic Physicians, the North American Board of Naturopathic Examiners and the regulatory bodies that regulate the practice of naturopathic medicine in Canada and the United States; (Council on Naturopathic Medical Education)
"dispense", in respect of a drug, means to provide a drug under the authority of a prescription, but does not include the administration or sale of that drug; (délivrer)
"drug" means a drug set out in Schedule I, II or III of the National Drug Schedules established by the National Association of Pharmacy Regulatory Authorities, as amended from time to time; (drogue)
"expanded register" means the expanded register of the Naturopathic Profession Register referred to in paragraph 2(1)(b); (registre étendu)
"general register" means the general register of the Naturopathic Profession Register referred to in paragraph 2(1)(a); (registre général) "Schedule I drug" means a drug set out in Schedule I of the National Drug Schedules referred to in the definition "drug"; (drogue mentionnée à l’Annexe I)
"substance" means anything, other than a drug, that is publicly available and which may include botanical tinctures, botanical powders or loose herbs, extracts, base creams, salves and ointments, homeopathic remedies, vitamins, minerals and amino acids. (substance)
Register
(1) The Naturopathic Profession Register is established and is divided into the following categories:
(a) general register;
(b) expanded register.
(2) The Naturopathic Profession Register may be maintained in an electronic format.
(3) Any person may, on request and during regular office hours, inspect the Naturopathic Profession Register.
Registration and Licensing
(1) For the purpose of section 10 of the Act, a person is eligible to be registered on the general register if the person
(a) has successfully completed a program of studies in naturopathic medicine offered by an accredited naturopathic school;
(b) has successfully passed
(i) the Naturopathic Physicians Licensing Examinations, Parts I and II, set by the North American Board of Naturopathic Examiners, or
(ii) the Clinical Sciences Examination and the Biomedical Examination, both set by the College of Naturopaths of Ontario;
(c) has successfully passed
(i) the oral and practical examinations set by the College of Naturopathic Physicians of British Columbia, or
(ii) the Ontario Clinical (Practical) Examinations in Naturopathic Manipulation, Acupuncture and Physical Examination/ Instrumentation, set by the College of Naturopaths of Ontario;
(d) meets one of the following criteria:
(i) within the two years immediately preceding the date the Registrar receives the person’s application, has completed the requirements in paragraphs (a), (b) and (c),
(ii) within the three years immediately preceding the date the Registrar receives the person’s application, has provided 1200 hours of professional services as a naturopath while registered as a member in good standing on the equivalent of the general or expanded register in a province or another territory or in another jurisdiction recognized by the Registrar;
(e) holds professional liability insurance, issued by a company authorized to carry on business in Canada, in at least the minimum amount approved by the Minister; and
(f) is authorized to work in Canada.
(2) For the purpose of section 10 of the Act, a person is eligible to be registered on the expanded register with respect to one or more of the activities listed in subsection 6(2) if the person
(a) meets the eligibility requirements for the general register set out in subsection (1); and
(b) has successfully completed accredited training to perform the activities for which they are applying for registration.
(1) An application by a person for registration on the general register and for the issuance of a licence under section 11 of the Act must include
(a) a written statement regarding
(i) the applicant’s intention to provide the services of the profession of naturopathic medicine in the Northwest Territories, and the location where those services will be provided, and
(ii) whether the applicant is entitled to practice naturopathic medicine in a province or another territory, and whether the applicant will provide those services in that province or territory;
(b) the results of the following checks obtained from the Royal Canadian Mounted Police and dated not more than six months before the date the application is submitted:
(i) criminal record check,
(ii) vulnerable sector check; and
(c) evidence satisfactory to the Registrar that the applicant meets the eligibility requirements set out in subsection 3(1).
(2) An application by a person for registration on the expanded register and for the issuance of a licence under section 11 of the Act must include
(a) the information and evidence set out in paragraphs (1)(a) to (c); and
(b) evidence of successful completion of the training referred to in paragraph 3(2)(b).
R-107-2024,s.2.
For the purpose of subsections 11(3), 14(4), 17(5) and 18(5) of the Act, the Registrar shall review an application within 60 days of receipt of all information and documentation required by the Registrar under the Act and these regulations as a part of that review.
Scope of Practice
(1) A registered member on the general or expanded register may, in the practice of naturopathic medicine, in accordance with their registration and licence and subject to any conditions imposed on the member’s licence,
(a) insert or remove instruments, devices or fingers
(i) beyond the cartilaginous portion of the ear canal,
(ii) beyond the point in the nasal passages where they normally narrow,
(iii) beyond the opening of the urethra for the purpose of obtaining diagnostic samples,
(iv) beyond the labia majora, but not beyond the cervix, for the purpose of examining the cervix, performing Pap smears and obtaining diagnostic samples, and
(v) beyond the anal verge, but not beyond the rectal-sigmoidal junction, for the purpose of a rectal or prostate exam;
(b) communicate a diagnosis to a patient that identifies, through an assessment using naturopathic techniques, a disease, disorder or dysfunction as the cause of the patient’s symptoms;
(c) perform a procedure on the tissue below the dermis or below the surface of the mucous membrane for the purpose of venipuncture;
(d) order and perform laboratory and non-laboratory tests;
(e) collect and interpret the results of laboratory and non-laboratory tests;
(f) administer a substance by inhalation; and
(g) compound and sell a substance.
(2) A registered member on the expanded register may, in addition to those activities listed in subsection (1), in accordance with their registration and licence and subject to any conditions imposed on that licence, do one or more of the following:
(a) perform surgery that is minor and that does not include sedation, general anesthesia or respiratory assistance;
(b) use electricity, in the course of performing surgery under paragraph (a), for the purpose of destroying tissue;
(c) cut a body tissue, administer anything by an invasive procedure on body tissue or perform an invasive procedure on body tissue below the dermis or the mucous membrane for the purpose of
(i) needle acupuncture, or
(ii) administering intravenous ozone, chelation therapy, prolotherapy or supplemental vitamins and minerals;
(d) prescribe, dispense, compound or administer a Schedule I drug, other than a drug set out in Schedule A;
(e) use a deliberate, brief and fast thrust to move the joints of the spine beyond the normal range but within the anatomical range of motion;
(f) insert or remove instruments, devices or fingers
(i) beyond the labia majora for the purpose of performing vaginal ozone therapy, or
(ii) beyond the anal verge for the purpose of performing hydro therapy, rectal ozone therapy or the Keesey technique for the reduction of hemorrhoids;
(g) perform hyperbaric oxygen therapy.
(3) A registered member on the general register shall not perform any of the activities listed in subsection (2).
(4) Notwithstanding any authorization to perform activities listed in subsections (1) and (2), registered members shall restrict themselves to performing those activities that they are competent to perform and to those that are appropriate to the member’s area of practice and the procedure being performed.
Licence Expiry and Renewal
A licence issued to a registered member expires on December 31 of each year.
An application by a registered member for renewal under section 14 of the Act must include
(a) a written statement regarding
(i) the member’s intention to provide the services of the profession of naturopathic medicine in the Northwest Territories, and the location where those services will be provided,
(ii) whether the member is entitled to practice naturopathic medicine in a province or another territory, and whether the member will provide those services in that province or territory,
(iii) whether the member was charged with or convicted of an offence under the Criminal Code (Canada) within the past year, and
(iv) whether the member was subject to a disciplinary complaint, investigation or hearing in any other jurisdiction within the past year;
(b) a written statement that the member has complied with the continuing competency requirements set out in section 9; and
(c) proof of professional liability insurance, issued by a company authorized to carry on business in Canada, in at least the minimum amount approved by the Minister.
Continuing Competency
(1) In this section, "continuing competency activity" means any of the following which contribute to a registered member’s knowledge or skill in the practice of naturopathic medicine:
(a) participation in courses, workshops, seminars or discussion groups, either as a presenter or facilitator, including time spent preparing to present or facilitate, or as an attendee;
(b) self-directed learning or study, including reading professional journals or other reference sources and publishing research;
(c) participation in Indigenous cultural awareness training.
(2) For the purpose of section 13 of the Act, a registered member on the general or expanded register shall complete, in each two-year reporting period beginning on November 1 of each even-numbered year and ending on October 31 of the following even-numbered year,
(a) 40 hours of continuing competency activities; and
(b) Basic Life Support or CPR for Health Care Providers (with AED) training.
(3) For the purpose of section 13 of the Act, a registered member on the expanded register shall complete, in addition to the requirements set out in subsection (2),
(a) in each two-year reporting period as set out in subsection (2), four hours of continuing competency activities related to each expanded scope activity in respect of which the member is registered and licenced; and
(b) in each four-year reporting period beginning on November 1 of every second even-numbered year and ending on October 31 of the second even-numbered year following the start of the reporting period, a medical emergency refresher course approved by the Minister.
(4) Notwithstanding subsections (2) and (3), if at the time of an application for renewal under section 14 of the Act, a member has been registered for less than two years, the Registrar may waive all or part of the requirements set out in this section.
(5) Notwithstanding paragraph (3)(b), if at the time of an application for renewal under section 14 of the Act, a member has been registered for less than four years, the Registrar may waive the requirement set out in that paragraph. R-072-2022,s.2.
(1) A registered member shall record all continuing competency activities completed by the member in a format approved by the Minister.
(2) A registered member shall retain the continuing competency record required under subsection (1) for a minimum of five years.
Standards, Guidelines and Code of Ethics
(1) In this section,
"Code of Ethics" means the Code of Ethics published by the College of Naturopathic Doctors of Alberta; (code de déontologie)
"Northwest Territories Guidelines for Naturopathic Doctors" means the Northwest Territories Guidelines for Naturopathic Doctors, published by the Department of Health and Social Services; (Lignes directrices des docteurs en naturopathie des Territoires du Nord-Ouest)
"Northwest Territories Standards of Practice for Naturopathic Doctors" means the Northwest Territories Standards of Practice for Naturopathic Doctors, published by the Department of Health and Social Services. (Normes de pratique des docteurs en naturopathie des Territoires du Nord-Ouest)
(2) The Northwest Territories Guidelines for Naturopathic Doctors and the Northwest Territories Standards of Practice for Naturopathic Doctors are adopted as amended from time to time.
(3) Subject to subsection (4), the Code of Ethics is adopted, as amended from time to time, as the code of ethics governing registered members on the general or expanded register.
(4) The Code of Ethics is adopted with any modifications the circumstances require, and a reference in the Code to
(a) "Alberta" shall be read as "Northwest Territories";
(b) "College" shall be read as "Standards of Practice for Naturopathic Practitioners"; and
(c) "CNDA Council" shall be read as "Government of the Northwest Territories".
(5) A registered member engaged in the practice of naturopathic medicine and providing the services of that profession shall do so in accordance with
(a) the Code of Ethics;
(b) the Northwest Territories Guidelines for Naturopathic Doctors;
(c) the Northwest Territories Standards of Practice for Naturopathic Doctors; and
(d) generally accepted professional standards and procedures.
Unprofessional Conduct
For the purpose of subsection 22(3) of the Act, unprofessional conduct includes providing a service that a registered member is not, at the time the service is provided, authorized under the Act and these regulations to provide.
Initial Review of Complaint
For the purpose of subsection 26(1) of the Act, the Complaints Officer shall complete their review and inquiry within 60 days of receipt of all information and documentation required by the Complaints Officer as a part of that review and inquiry.
Titles
(1) The use of the following titles and their abbreviations is reserved to registered members:
(a) Naturopathic Doctor and its initials N.D.;
(b) Naturopathic Practitioner;
(c) Naturopathic Physician;
(d) Naturopath;
(e) Doctor of Naturopathic Medicine and its initials N.M.D.;
(f) Doctor of Naturopathy.
(2) Subsection (1) does not apply for a period of six months following the date on which these regulations come into force.
Fees
The fees payable under the Act and these regulations are set out in Schedule B.
Coming into Force
These regulations come into force on the day on which section 5 of the Health and Social Services Professions Act, SNWT 2015, c.4 comes into force.
SCHEDULE A
(paragraph 6(2)(d))
Excluded Schedule I Drugs
Part 1. Acute Perinatal Care Agents
1. Beractant
2. Colfosceril or its derivatives
3. Nitric Oxide
4. Poractant Alfa
Part 2. Agents used for Emergency Purposes Only
1. Adenosine or its salts
2. Amiodarone or its salts or derivatives
3. Atropine or its salts
4. Dopamine or its salts
5. Procainamide or its salts
6. Propafenone or its salts
7. Verapamil or its salts
Part 3. Antiarrhythmic Agents
1. Bretylium tosylate
2. Disopyramide or its salts
3. Esmolol or its salts
4. Flecainide or its salts
5. Ibutilide or its salts or derivatives
6. Isoproterenol or its salts
7. Methoxamine or its salts
8. Mexiletine or its salts
9. Procainamide or its salts
10. Propafenone or its salts
11. Quinidine salts
12. Sotalol or its salts
13. Tocainide or its salts
14. Verapamil or its salts
Part 4. Antibiotics with narrow therapeutic index
1. Amikacin or its salts or derivatives
2. Amphotericin B or its salts or derivatives
3. Apramycin or its salts or derivatives
4. Atovaquone or its salts or derivatives
5. Aztreonam or its salts or derivatives
6. Bacitracin or its salts or derivatives, except when used for intravenous therapy
7. Candicidin or its salts or derivatives
8. Carbapenem or its salts or derivatives
9. Carbomycin or its salts or derivatives
10. Caspofungin or its salts or derivatives
11. Cephalosporin or its salts or derivatives
12. Cilastatin or its salts or derivatives
13. Colistin or its salts or derivatives
14. Dalfopristin or its salts or derivatives
15. Dihydrostreptomycin or its salts or derivatives
16. Enrofloxacin or its salts or derivatives
17. Gentamicin when used for intravenous therapy
18. Grepafloxacin or its salts or derivatives
19. Marbofloxacin or its salts or derivatives
20. Mecillinam or its salts or derivatives
21. Mezlocillin or its salts or derivatives
22. Quinupristin or its salts or derivatives
23. Streptomycin or its salts or derivatives
24. Tazobactam or its salts or derivatives
25. Tobramycin or its salts or derivatives when used for intravenous therapy
26. Trovafloxacin or its salts or derivatives
27. Vancomycin or its salts or derivatives
28. Virginiamycin or its salts or derivatives
29. Voriconazole or its salts or derivatives
Part 5. Anticonvulsants
1. Carbamazepine, except when used for pain management
2. Gabapentin or its salts or derivatives, except when used for pain management
3. Lamotrigine or its salts
4. Methoin (mephenytoin) or its salts
5. Oxcarbazepine
6. Phenacemide
7. Pregabalin or its salts or derivatives, except when used for pain management
8. Primidone
9. Topiramate
10. Trimethadione
11. Valproic Acid or its salts
12. Vigabatrin or its salts or derivatives
Part 6. Antineoplastic Agents
1. 5-Fluorouracil when used for intravenous therapy
2. Apalutamide or its salts
3. Cyproterone Acetate
4. Darolutamide
5. Flutamide
6. Hydroxyurea
7. Vinblastine or its salts
8. Vincristine or its salts
9. Vindesine or its salts
10. Vinorelbine or its salts Part 7. Antiparkinson Agents
1. Benserazide or its salts
2. Biperiden or its salts
3. Entacapone
4. Safinamide or its salts or derivatives
5. Tolcapone
Part 8. Antipsychotic Agents
1. Acepromazine or its salts
2. Butaperazine or its salts
3. Chlorpromazine or its salts
4. Chlorprothixene or its salts
5. Clozapine or its salts
6. Flupenthixol or its salts or derivatives
7. Fluphenazine or its salts
8. Haloperidol
9. Lithium or its salts in doses >150mg equivalent of lithium carbonate
10. Loxapine or its salts
11. Mesoridazine or its salts
12. Methotrimeprazine or its salts
13. Olanzapine or its salts
14. Pericyazine or its salts
15. Perphenazine or its salts
16. Pimozide
17. Pipotiazine or its salts
18. Prochlorperazine or its salts
19. Promazine or its salts
20. Quetiapine or its salts
21. Remoxipride or its salts
22. Risperidone or its salts
23. Tetrabenazine or its salts
24. Thiethylperazine or its salts
25. Thioridazine or its salts
26. Thiothixene or its salts
27. Trifluoperazine or its salts
28. Triflupromazine or its salts
29. Trimeprazine or its salts
30. Zuclopenthixol or its salts or derivatives
Part 9. Antitubercular agents used for other infections
1. Isoniazid Part 10. Antiviral Agents
1. Foscarnet Sodium
2. Ganciclovir or its salts
3. Idoxuridine
4. Ribavirin
5. Valganciclovir or its salts or derivatives
Part 11. Botulinum Toxins
1. Botulinum Toxin Type A, except when used for pain management
2. Botulinum Toxin Type B, except when used for pain management
Part 12. Disease Modifying Agents
1. Denosumab
2. Azathioprine, except when used for continuation therapy
3. Methotrexate, except when used for continuation therapy
4. Penicillamine, except when used for chelation therapy
Part 13. Emergency Medicine Agents
1. Amrinone or its salts
2. Bosentan or its salts or derivatives
3. Digoxin Immune Fab
4. Dobutamine or its salts
5. Drotrecogin
6. Fomepizole or its salts
7. Hetastarch or its derivatives
8. Leucovorin or its salts
9. Milrinone or its salts
10. Physostigmine Salicylate, except in preparations for oral or topical use
11. Sodium Nitroprusside or its salts or derivatives
Part 14. Endocrine Agents/Endocrine Diagnostic Agents
1. Gonadorelin or its salts
2. Mepacrine or its salts
3. Metyrapone or its salts
4. Nafarelin or its salts or derivatives
5. Pegvisomant
6. Protirelin
7. Thyrotropin Alfa
8. Quinagolide or its salts
9. Sermorelin or its salts
10. Terlipressin or its salts
11. Triiodothyropropionic Acid
12. Trilostane
Part 15. Iron Derivatives
1. Iron when used for intravenous therapy
Part 16. Obstetrical Agents
1. Carbetocin or its salts
2. Oxytocin
3. Ritodrine or its salts
Part 17. Ophthalmic Agents
1. Bimatoprost, except when used for the treatment of hypotrichosis of the eyelid to a maximum strength of 0.03% w/v
2. Brimonidine or its salts
3. Carbachol
4. Dexamethasone, except for ophthalmic use
5. Dipivefrin or its salts
6. Dorzolamide or its salts
7. Ecothiophate or its salts
8. Latanoprostene Bunod or its salts or derivatives
9. Levobunolol or its salts
10. Methazolamide or its salts
11. Pegaptanib
12. Pilocarpine or its salts
13. Prednisolone except for ophthalmic use
14. Trifluridine
15. Unoprostone or its salts
16. Verteporfin
Part 18. Thrombolytic, Hemostatic and Anti-platelet Agents
1. Alteplase or its salts or derivatives
2. Aminocaproic acid
3. Aprotinin
4. Argatroban or its salts or derivatives
5. Bivalirudin
6. Danaparoid or its salts or derivatives
7. Enoxaparin or its salts
8. Eptifibatide or its salts
9. Reviparin or its salts
10. Streptokinase / streptodornase
11. Tenecteplase or its salts or derivatives
12. Tirofiban or its salts or derivatives
13. Tranexamic acid Part 19. Other Excluded Schedule I Drugs
1. Acetohexamide
2. Adalimumab
3. Adefovir or its salts
4. Agalsidase Alfa
5. Aldesleukin
6. Alemtuzumab
7. Alkyl Nitrites
8. Alprazolam
9. Altretamine
10. Amifostine or its salts
11. Aminoglutethimide
12. Aminopterin or its salts
13. Aminopyrine or its derivatives
14. Amprenavir or its salts or derivatives
15. Amsacrine or its salts
16. Anagrelide or its salts
17. Anakinra or its salts or derivatives
18. Anastrozole
19. Ancestim
20. Anileridine
21. Anti-thymocyte Globulin
22. Atazanavir or its salts
23. Atracurium Besilate
24. Auranofin
25. Aurothioglucose
26. Basiliximab
27. Bevacizumab
28. Bicalutamide
29. Bleomycin
30. Bortezomib
31. Bromazepam or its salts
32. Buprenorphine
33. Buserelin or its salts
34. Busulfan
35. Butalbital
36. Butorphanol
37. Cabergoline or its salts
38. Capecitabine or its salts or derivatives
39. Carboplatin
40. Carmustine
41. Cetrorelix or its salts
42. Cetuximab
43. Chlorambucil or its salts or derivatives
44. Chlordiazepoxide or its salts
45. Chlorisondamine or its salts
46. Choriogonadotropin Alfa
47. Cinacalcet or its salts
48. Cisplatin
49. Cladribine or its salts
50. Clobazam or its salts
51. Clonazepam or its salts
52. Clorazepic acid or its salts
53. Codeine, when prescribed as a single entity or when included in a preparation containing more than 8 mg per dosage unit
54. Cyclophosphamide
55. Cycloserine
56. Cyclosporine
57. Cytarabine or its salts
58. Dacarbazine
59. Daclizumab
60. Dactinomycin
61. Daunorubicin or its salts
62. Delavirdine or its salts
63. Desflurane
64. Dexrazoxane or its salts
65. Diazepam or its salts
66. Didanosine or its salts or derivatives
67. Diethylstilbestrol or its derivatives
68. Dihydrotachysterol
69. Dinoprostone or its salts or derivatives
70. Docetaxel or its derivatives
71. Doxacurium chloride
72. Doxercalciferol or its derivatives
73. Doxorubicin or its salts
74. Droperidol or its salts
75. Edrophonium chloride
76. Efavirenz
77. Emtricitabine
78. Enflurane
79. Enfuvirtide
80. Epirubicine or its salts
81. Erythropoietin
82. Estazolam or its salts
83. Estramustine or its salts
84. Etanercept
85. Ethambutol or its salts
86. Ethchlorvynol
87. Ethionamide or its salts
88. Ethoheptazine or its salts
89. Etoposide or its derivatives
90. Exemestane
91. Fenfluramine or its salts
92. Fentanyl
93. Filgrastim
94. Flucytosine
95. Fludarabine or its salts or derivatives
96. Flumazenil
97. Fluorouracil or its derivatives, except when used for intravenous therapy
98. Flurazepam or its salts
99. Flutamide
100. Follicle stimulating hormone
101. Formestane or its salts or derivatives
102. Fulvestrant
103. Gallamine triethiodide
104. Ganirelix or its salts or derivatives
105. Gefitinib
106. Gemcitabine or its salts
107. Glatiramer or its salts
108. Gold or its salts
109. Goserelin or its salts
110. Halazepam or its salt
111. Halofantrine or its salts
112. Halothane
113. Hydrocodone
114. Hydromorphone
115. Hydroxychloroquine or its salts
116. Idarubicin or its salts
117. Ifosfamide
118. Imatinib or its salts
119. Imiglucerase
120. Indinavir or its salts
121. Infliximab
122. Interferon
123. Iproniazid or its salts
124. Irinotecan or its salts
125. Isoflurane
126. Ivermectin or its derivatives
127. Kanamycin or its salts or derivatives
128. Ketamine or its salts
129. Ketazolam or its salts
130. Lamivudine or its salts
131. Laronidase
132. L-Asparaginase
133. Leflunomide or its salts
134. Letrozole
135. Leuprolide or its salts
136. Levallorphane or its salts
137. Levamisole or its salts
138. Levorphanol
139. Lincomycin or its salts or derivatives
140. Linezolid or its salts
141. Lomefloxacin or its salts
142. Lomustine
143. Lopinavir
144. Loracarbef or its salts or derivatives
145. Lorazepam or its salts
146. Mazindol or its salts
147. Mecamylamine or its salts
148. Mechlorethamine or its salts
149. Melphalan
150. Menotropins
151. Meperidine (pethidine)
152. Mercaptopurine
153. Meropenem or its salts or derivatives
154. Mesna
155. Metaraminol Bitartrate
156. Methadone
157. Methaqualone
158. Midazolam or its salts
159. Midodrine or its salts
160. Miglustat
161. Mitomycin or its salts
162. Mitotane
163. Mitoxantrone or its salts
164. Mivacurium Chloride
165. Molgramostim in amounts greater than 8 mg per dosage unit
166. Morphine
167. Muromonab-CD3
168. Mycophenolic Acid or its salts or derivatives
169. Nalmefene or its salts
170. Nelfinavir or its salts
171. Neostigmine salts
172. Netilmicin or its salts or derivatives
173. Nevirapine or its salts
174. Nikethamide
175. Nilutamide
176. Nitrazepam or its salts
177. Normethadone
178. Octreotide
179. Oxazepam or its salts
180. Oxycodone
181. Paclitaxel or its derivatives
182. Palivizumab
183. Pamidronic acid or its salts
184. Pancuronium or its salts
185. Pegfilgrastim
186. Pemetrexed or its salts
187. Pentamidine or its salts
188. Pentazocine
189. Pentolinium Tartrate
190. Pentostatin or its salts
191. Perflutren
192. Phentolamine or its salts
193. Pipobroman
194. Porfimer or its salts
195. Pralidoxime or its salts
196. Prazepam or its salts
197. Prodilidine or its salts
198. Propofol
199. Propoxyphene
200. Pyrazinamide
201. Pyridostigmine Bromide
202. Raltitrexed or its salts or derivatives
203. Rasburicase
204. Rifabutin or its salts
205. Riluzole or its salts
206. Ritonavir
207. Rituximab
208. Rocuronium Bromide
209. Rofecoxib
210. Saquinavir or its salts or derivatives
211. Sargramostim
212. Sevelamer Hydrochloride
213. Sirolimus or its derivatives
214. Sodium Aurothiomalate
215. Stavudine
216. Streptozocin
217. Succinylcholine or its salts
218. Sufentanil
219. Suxamethonium Chloride
220. Tacrolimus or its derivatives
221. Tegafur or its salts
222. Temazepam or its salts
223. Temozolomide or its salts
224. Teniposide
225. Tenofovir or its salts or derivatives
226. Thalidomide
227. Thiocarlide
228. Thioguanine
229. Thiotepa
230. Tiludronic Acid or its salts
231. Tipranavir or its salts
232. Topotecan or its salts
233. Toremifene or its salts
234. Trastuzumab
235. Treosulfan
236. Treprostinil or its salts
237. Tretamine
238. Triazolam or its salts
239. Trimethaphan Camsylate
240. Trimetrexate or its salts
241. Troglitazone
242. Tubocurarine or its salts
243. Valrubicin or its derivatives
244. Vecuronium Bromide
245. Viomycin or its salts or derivatives
246. Zalcitabine or its salts
247. Zidovudine
248. Zoledronic Acid or its salts or derivatives
SCHEDULE B (section 14)
Fees
1. Designation Application fee................................................................ $0
2. Initial Application, Registration and Licence fee - General Register.............................. $2,343
3. Initial Application, Registration and Licence fee - Expanded Register ............................ $2,443
4. Fee for Additional Expanded Register Activity............................................... $100
5. Licence Renewal fee - General and Expanded Register........................................ $2,068
6. Late fee for Licence Renewal ............................................................ $385
7. Reinstatement fee - General Register...................................................... $2,068
8. Reinstatement fee - Expanded Register .................................................... $2,343
9. Fee for Certificate of Standing............................................................. $26
R-089-2025,s.2.